Singapore Health Services Pte. Ltd.;Agency for Science, Technology and Research;Tessa Therapeutics Ltd.
发明人:
CONNOLLY, John,TOH, Han Chong,HOPKINS, Richard
申请号：
DK16871163
公开号：
DK3384052T3
申请日:
2016.09.09
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
A method for predicting whether a patient will be a long-term survivor on treatment of a disease by adoptive cell transfer (ACT), is disclosed comprising: (i) analyzing a blood-derived sample obtained from the patient for one or more prognostic markers of long-term survival on treatment of a disease by ACT, and； (ii) based on the analysis of step (i), predicting whether the patient will be a long-term survivor on treatment of the disease by ACT. Also disclosed are methods for treating a patient by ACT, methods for selecting a patient for treatment by ACT, and methods for selecting a patient for treatment of a disease by ACT.
